Trial Profile
Study on clinical and parasitological outcome of (a) ACT, A-L for falciparum malaria and (b) P-A for falciparum and vivax malaria in Ta-mu township, Sagaing Region
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 07 Aug 2019
Price :
$35
*
At a glance
- Drugs Artesunate/pyronaridine (Primary) ; Artemether/lumefantrine
- Indications Falciparum malaria; Vivax malaria
- Focus Therapeutic Use
- 07 Aug 2019 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 10 Sep 2018 New trial record